LIC launches three new insurance plans from 19 Oct 2026

⚡ Key Financial Takeaways

LIC’s New Jeevan Dhara‑II provides a deferred annuity that begins payouts after a chosen waiting period.

Health Shield delivers a predetermined sum for hospitalisation and other health expenses.

New Cancer Cover offers lump‑sum payouts for a list of specified cancer diagnoses.

All three policies become available to customers from 19 October 2026.

The launch expands LIC’s portfolio in retirement, health and critical‑illness segments.

💡 Why It Matters

The three policies address pressing financial risks for Indian households: insufficient retirement income, escalating medical expenses and the financial shock of cancer treatment. By offering a deferred annuity, a fixed health benefit and a cancer‑specific payout, LIC aims to fill gaps in the market and reinforce its position as a comprehensive insurer. The launch also reflects broader trends in India’s insurance sector, where insurers are diversifying beyond traditional life cover to meet evolving consumer needs.

LIC expands its product suite The Life Insurance Corporation of India (LIC) announced that three new insurance plans will be launched on 19 October 2026. The offerings target three distinct needs: post‑retirement income, routine health expenses and financial protection against cancer.

New Jeevan Dhara‑II – deferred annuity Jeevan Dhara‑II is positioned as a deferred annuity. Policyholders can select a deferral period after which regular income payments commence, helping retirees smoothen cash flow in later years. The plan’s flexibility allows customers to align the start of payouts with personal retirement timelines.

Health Shield – fixed health benefits Health Shield provides a fixed sum‑insured for hospitalisation, surgeries and other medical costs. Unlike traditional health policies that reimburse actual expenses, this product pays a predetermined amount irrespective of the actual bill, simplifying claim settlement.

New Cancer Cover – payouts for specified cancers The New Cancer Cover is a critical‑illness product that triggers a lump‑sum payout upon diagnosis of cancers listed in the policy wording. The payout can be used for treatment, recovery or any other financial need, offering a safety net against the high cost of cancer care.

Market impact By adding a deferred annuity, a fixed‑benefit health plan and a cancer‑specific cover, LIC is broadening its reach across three high‑growth insurance segments in India. The move comes as the country’s ageing population, rising healthcare costs and increasing cancer incidence drive demand for specialised protection.

What customers should consider Potential buyers need to compare premium rates, waiting periods and coverage limits with existing LIC products and competitors. Understanding the list of cancers covered and the exact health benefit amount will be crucial for informed decisions.

🏛️ Background & Context

LIC, India’s largest life insurer, regularly updates its product portfolio to align with demographic shifts and regulatory changes. Earlier this year, the regulator approved several new health and pension products across the industry, prompting insurers to expand their offerings. The introduction of a deferred annuity and a cancer‑specific cover follows similar moves by private insurers seeking to capture niche segments.

India’s median age is rising, and the World Health Organization estimates a steady increase in cancer cases, underscoring the relevance of targeted protection.

👁️ What To Watch Next

Watch for the official premium structures and underwriting guidelines that LIC will release closer to the launch date. Regulatory approvals, consumer response and the pricing of these plans will shape their market uptake. Additionally, any subsequent amendments to the list of covered cancers or health benefit limits could affect policy attractiveness.